Health Care & Life Sciences » Pharmaceuticals | Sunflower Pharmaceuticals Group Co. Ltd.

Sunflower Pharmaceuticals Group Co. Ltd. | Mutual Funds

Mutual Funds that own Sunflower Pharmaceuticals Group Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
HSBC Jintrust Large Cap Equity Fund
7,057,484
1.37%
7,057,484
2.19%
12/31/2017
6,940,054
1.34%
6,940,054
1.67%
12/31/2017
3,439,154
0.67%
3,439,154
6.33%
12/31/2017
Yinhua Prosperity Theme Equity Fund
1,684,964
0.33%
1,684,964
0.47%
12/31/2017
China AMC Blue Chip Core Fund
999,870
0.19%
999,870
0.52%
12/31/2017
960,184
0.19%
960,184
2.5%
12/31/2017
939,772
0.18%
939,772
0.71%
12/31/2017
852,686
0.17%
852,686
6.39%
12/31/2017
Fortune SG Health Care & Bio-Agiculture Industries Fund
710,454
0.14%
710,454
3.63%
12/31/2017
688,200
0.13%
688,200
3.41%
12/31/2017

About Sunflower Pharmaceuticals Group Co.

View Profile
Address
No. 18 Donghu Road, Jizhong Area
Harbin Heilongjiang 150078
China
Employees -
Website http://www.kuihuayaoye.com
Updated 07/08/2019
Sunflower Pharmaceutical Group Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceutical products. It focuses on proprietary Chinese medicines, chemical drugs, bio-pharmaceuticals, and tonic health care products. Its products include children's medication, digestive system medication, respiratory and cold medicine, gynecological drugs, rheumatism bone disease medication, and cardiovascular and cerebrovascular drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.